NCT00241943

Brief Summary

The investigators hypothesize that a well-designed hepatitis C (HCV) video education curriculum for active drug injectors will lead to measurable improvements in HCV testing rates, HAV and HBV vaccination rates, as well as knowledge and attitudes about this condition. The investigators will use a short 10 minute video designed for active drug users to and assess its impact vs. a usual-care counseling intervention. The investigators will measure and compare its impact at baseline, 4 weeks after video viewing, and 12 weeks after intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
103

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2005

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 19, 2005

Completed
13 days until next milestone

Study Start

First participant enrolled

November 1, 2005

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2007

Completed
Last Updated

December 9, 2008

Status Verified

December 1, 2008

Enrollment Period

1.7 years

First QC Date

October 18, 2005

Last Update Submit

December 8, 2008

Conditions

Hepatitis COpiate Dependence

Keywords

Hepatitis CHeroinPopulations at risktestingvaccination

Outcome Measures

Primary Outcomes (3)

  • HCV testing rates, intervention vs. usual care

  • HAV vaccination rates, intervention vs. usual care

  • HBV vaccination rates, intervention vs. usual care

Secondary Outcomes (3)

  • Improvement in knowledge, intervention vs. usual care

  • Improvement in attitudes toward behavior change, intervention vs. usual care

  • Improvement in motivations toward behavior change, intervention vs. usual care

Interventions

Hepatitis C educational videoPROCEDURE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 and older
  • Attendance at syringe exchange program

You may not qualify if:

  • Unable to provide informed consent
  • Not interested in study
  • Not able to speak or understand English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

HEPPAC

Oakland, California, 94601, United States

Location

MeSH Terms

Conditions

Hepatitis COpioid-Related Disorders

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsHepatitis, Viral, HumanVirus DiseasesFlaviviridae InfectionsRNA Virus InfectionsHepatitisLiver DiseasesDigestive System DiseasesNarcotic-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Diana L. Sylvestre, MD

    Organization to Achieve Solutions in Substance Abuse (OASIS)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 18, 2005

First Posted

October 19, 2005

Study Start

November 1, 2005

Primary Completion

August 1, 2007

Study Completion

August 1, 2007

Last Updated

December 9, 2008

Record last verified: 2008-12

Locations

US(1)